e.g. Tata motors, Reliance MF, 500570

Zenith Drugs Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:

Balance sheet

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 22 Mar ' 21 Mar ' 20
Sources of funds
Owner's fund
Equity share capital 17.15 17.15 0.40 0.40 0.40
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 52.23 45.07 12.45 9.24 6.17
Loan funds
Secured loans 48.57 23.93 16.79 15.48 12.07
Unsecured loans - - - - -
Total 117.95 86.15 29.64 25.12 18.64
Uses of funds
Fixed assets
Gross block 52.15 19.87 16.80 14.23 6.40
Less : revaluation reserve - - - - -
Less : accumulated depreciation 11.89 8.93 6.35 5.01 -
Net block 40.26 10.94 10.45 9.21 6.40
Capital work-in-progress 3.10 3.91 - - 2.61
Investments - 0.03 0.03 - -
Net current assets
Current assets, loans & advances 118.12 119.30 55.71 37.33 34.72
Less : current liabilities & provisions 43.53 48.02 36.55 21.42 25.08
Total net current assets 74.59 71.28 19.16 15.91 9.64
Miscellaneous expenses not written - - - - -
Total 117.95 86.15 29.64 25.12 18.64
Notes:
Book value of unquoted investments - 0.03 - - -
Market value of quoted investments - - - - -
Contingent liabilities 12.82 7.72 - - -
Number of equity sharesoutstanding (Lacs) 171.49 171.49 4.00 4.00 4.00
Close
Add Zenith Drugs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Zenith Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback